Triple Giving November OMF logo

 TRIPLE YOUR IMPACT during Triple Giving November | All Donations to OMF are TRIPLED through December 3

Search
Close this search box.

Personalized Medicine

This week for #OMFScienceWednesday we look in our archives and re-share with you an earlier post about personalized medicine.

In honor of this week’s conference at Stanford University, on this #OMFScienceWednesday we ask the question: what is personalized health? Whether you call it personalized medicine, precision health, or P4 medicine, we are talking about a current revolution in the way health and disease are being studied, and the way healthcare is being practiced. This means we are moving away from the one-size-fits-all approach to therapies, and towards more tailored ones that account for individual variations at the clinical and molecular level. This means we are aiming to predict the risk and eventually prevent the onset of disease. This means a data-driven revolution, that uses the cutting-edge molecular technologies we talked about last week and sophisticated big data analysis, to predict the best ways to treat disease and maintain health in each person. This means empowering patients to take a more active role in their own healthcare. This means focusing on turning from reactive (treating disease) to proactive (maintaining wellness).

Personalized health approaches to research are especially exciting in ME / CFS because of how complex and variable this disease is across patients. This is why OMF funded the big data study on severely ill patients (/mecfs-severely-ill-big-data-study/). We already know that different patients respond to different treatments, and personalized health research will help us not only to understand why that is, but to find even better treatments or combinations thereof. This is already starting to happen in cancer, where genome sequence information is used to select the most effective drugs for individual patients.

Much of the research OMF supports takes place at Stanford Medicine. Read more about Stanford Medicine’s commitment to precision health in research, in Dean Lloyd Minor’s Forbes op-ed: http://med.stanford.edu/…/dean-minor-on-precision-health.ht…

Dean Minor is now kicking off the Personalized Health conference at Stanford University, and Ron Davis will be speaking there about ME / CFS research on Friday afternoon. See the entire program here: http://bit.ly/2jn5HYR and follow the live Twitter feed here: http://twitter.com/hashtag/PH17F

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669